期刊文献+

降钙素原对非ST段抬高急性冠脉综合征合并全身炎症反应综合征患者治疗策略的指导作用分析 被引量:6

Guiding Function of Procalcitonin in Treatment Strategy of Non-ST-segment Elevation Acute Coronary Syndrome Complicated by Systemic Inflammatory Response Syndrome
下载PDF
导出
摘要 目的对比非ST段抬高急性冠脉综合征(NST-ACS)合并全身炎症反应综合征(SIRS)患者早期介入策略与降钙素原(PCT)指导下介入策略的优劣及抗菌药物使用情况。方法选择2010年6月—2012年8月首都医科大学附属复兴医院行择期经皮冠状动脉介入治疗(PCI)的NST-ACS患者146例为研究对象,采用随机数字表法分为A、B 2组。A组(n=73)行早期(<72 h)PCI治疗并根据传统炎症指标决定是否应用抗菌药物。B组(n=73)根据入院时PCT水平再分为B1(PCT≥2.0μg/L):应用抗菌药物治疗并择期(≥72 h)行PCI;B2(0.5μg/L≤PCT<2.0μg/L):根据传统炎症指标经验性决定PCI时机和抗菌药物的应用;B3(PCT<0.5μg/L):行早期(<72 h)PCI,不应用抗菌药物治疗。对比A、B 2组患者抗菌药物使用情况、平均住院天数及术后30 d不良事件的差异。结果在B组分组中,B1组患者4例,B2组13例(其中7例应用抗菌药物治疗),B3组56例(其中1例因明确泌尿系统感染而应用抗菌药物)。A组较B组抗菌药物使用率和平均住院天数升高,差异均有统计学意义(P<0.05)。术后30d,B组缺血事件、肾功能恶化及总终点事件发生率均低于A组,差异有统计学意义(P<0.05)。结论应用PCT指导NST-ACS合并SIRS患者的治疗策略,可以优化介入时机的选择,促进抗菌药物的合理化应用,减少不良事件的发生。 Objective To compare the early intervention strategy with intervention strategy guided by procalcitonin (PCT) for patients with non - ST - segment elevation acute coronary syndrome ( NST - ACS) combined with systemic inflammato- ry response syndrome (SIRS) and the uses of antibacterial drugs. Methods A total of 146 NST - ACS patients with elective percutaneous coronary intervention (PCI) in Fuxing Hospital from June 2010 to August 2012 were assigned randomly into groups A (n = 73 ), B (n = 73). Group A were given early PCI ( 〈 72 h) and antibacterial drug use based on traditional inflammatory markers. Group B were subdivided, based on admission PCT values, groups B1 [ n = 4, PCT ≥ 2.0 μg/L, using antibiotic therapy and selective PCI (1〉72 h)], B2 (0. 5 μg/L≤PCT 〈2. 0 μg/L, intervention timing and use of antibacterial decided on traditional inflammatory markers, n = 13, 7 used antibiotic therapy), B3 [ PCT 〈 0. 5 μg/L, early PCI ( 〈 72 h ) without antibiotic therapy, n = 56, 1 used antibacterial drugs due to urinary system infection]. Uses of antibacterial, average hospital stays and adverse reactions 30d after operation were compared between groups A, B. Results There was significant difference in antibacterial drug use rate and average hospital stay between 2 groups ( P 〈 0. 05 ). The incidence of renal function deteriora- tion and cardiac ischemic events was lower in group B than in group A 30 d after operation, the difference was significant (P 〈 0.05 ). Conclusion PCT - guided treatment tragedy combined with SIRS for NST - ACS patients can optimize the timing of in- tervention to promote rational use of antibacterial to reduce the incidence of adverse events.
出处 《中国全科医学》 CAS CSCD 北大核心 2013年第15期1708-1710,共3页 Chinese General Practice
关键词 降钙素原 全身炎症反应综合征 非ST段抬高急性冠脉综合征 血管成形术 经腔 经皮冠状动脉 Procalcitonin Systemic inflammatory response syndrome Non - ST - segment elevation acute coronary syndrome Angioplasty, transluminal, percutaneous coronary
  • 相关文献

参考文献13

二级参考文献84

共引文献2365

同被引文献58

  • 1张伟丽,宋雷,陈宇,刘继斌,吴永健,惠汝太.急性冠脉综合征的药物基因组学研究进展[J].中国分子心脏病学杂志,2011,11(4):251-256. 被引量:2
  • 2高学忠,马建军,阿米娜.马木提.急性冠脉综合征患者PCI术后抑郁症危险因素分析[J].山东医药,2013,53(30):33-34. 被引量:6
  • 3柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量:2125
  • 4Pietruszynski R, Markuszewski L, Masiarek K, et al. Role of preprocedural glutathione concentrations in the prediction of major adverse cardiac events in patients with acute coronary syndrome treated with percutaneous coronary intervention[J]. Pol Arch Med Wewn, 2013,123 (5) : 228-237.
  • 5O'Gara PT, Kushner FG, Ascheim DD, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J]. J Am Coll Cardiol, 2013,61(4) :e78-140.
  • 6Sinning CR, Sinning JM, Schulz A, et al. Association of serum procalcitonin with cardiovascular prognosis in coronary artery dis- ease[J]. Circ J, 2011,75(5) :1184-1191.
  • 7Jones AE, Flechtl JF. Procalcitonin test in the diagnosis of bactere- mia; a meta-analysis[J]. Ann Emerg Med, 2007,50(12) :34-41.
  • 8Ataoglu HF, Yilmaz F, Uzunhasan I, et al. Procalcitonin :a novel cardiac marker with prognostic value in acute coronary syndrome [J]. J Int Med Res, 2010,38(1) :52-61.
  • 9Ming-Shian Tsai,Yu-Fen Li,Cheng-Li Lin,Yao-Chun Hsu,Po-Huang Lee,Fung-Chang Sung,Chia-Hung Kao.Long-term risk of acute coronary syndrome in patients with cholangitis: A 13-year nationwide cohort study[J].European Journal of Internal Medicine.2014(5)
  • 10Nicole K. Gillis,Cynthia Arslanian-Engoren,Laura M. Struble.Acute Coronary Syndromes in Older Adults: A Review of Literature[J].Journal of Emergency Nursing.2014(3)

引证文献6

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部